In 2025, Eris Lifesciences conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 |
|---|---|---|
Total Waste Generated | 116.18a | 108.65a |
Total Waste Recovered | 114.52a | 105.65a |
Total Hazardous Waste Generated | 2.54a | 3.29a |
Non-Hazardous Waste Disposed | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Eris Lifesciences generated a total of 116metric tonnes of waste.a
Of this amount, 98.57% of Eris Lifesciences's total waste generated was recovered through methods such as recycling, reuse, or composting, while 131.71% was disposed of through landfilling, incineration, or combustion.a
In 2025, Eris Lifesciences reported a total waste generation of 116 metric tonnes, of which 98.57% was recovered through recycling, reuse, or composting.This high recovery rate suggests that Eris Lifesciences has implemented strong circular economy practices and actively prioritizes sustainable waste management.a
Since 2025, Eris Lifesciences's total waste generation has increased by 6.93%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Over the same period, Eris Lifesciences's waste recovery rate increased by 1.37%.a
In 2025, Eris Lifesciences generated a total of 116 metric tonnes of waste.a
Of this amount, 2.19% of Eris Lifesciences's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.97.81% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2025, Eris Lifesciences's total waste generation has increased by 6.93%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.a
Since 2025, Eris Lifesciences's hazardous waste generation has increased by 27.8%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..a
Overall, Eris Lifesciences's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a
In 2025, Eris Lifesciences reported that 3 metric tonnes of its total waste output were classified as hazardous. This represents 2.19% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.Approximately 34.65% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.a